Le Lézard
Classified in: Health
Subjects: MAV, CFG

Media Advisory - Prime Minister's itinerary for Thursday, March 7, 2024


OTTAWA, ON, March 6, 2024 /CNW/ -

Note: All times local

Greater Toronto Area, Ontario


The Prime Minister will meet with nurses and physicians.


Note for media:

  • Pooled photo opportunity

The Prime Minister will make a pharmacare announcement. The Deputy Prime Minister
and Minister of Finance, Chrystia Freeland, and the Minister for Women and Gender
Equality and Youth, Marci Ien, will also be in attendance. A media availability will follow.


Notes for media: 

  • Open coverage
  • Media are asked to arrive no later than 10:30 a.m.
  • Media interested in participating can contact [email protected] for details.

The Prime Minister will meet with health care professionals and non-profit diabetes
advocates.


Note for media:

  • Pooled photo opportunity

This document is also available at https://pm.gc.ca

SOURCE Prime Minister's Office


These press releases may also interest you

at 08:00
Kane Biotech to Release First Quarter 2024 Financial Results on May 23, 2024
Kane Biotech Inc. (the "Company" or "Kane Biotech"), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, will release its first quarter 2024...

at 08:00
Cannabix Technologies and Omega Laboratories Inc. Enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology
Cannabix Technologies Inc. (the "Company" or "Cannabix") reports that it has entered into a strategic partnership and development agreement dated May 15, 2024 (the "Agreement") with Omega Laboratories Inc of Ohio, USA ("Omega Laboratories" or...

at 07:35
FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/BAL Therapy for Relapsed or Refractory Metastatic Colorectal Cancer
Agenus Inc. ("Agenus") , a leader in discovering and developing novel immunological agents to treat various cancers, today announced it will conduct a Type B End-of-Phase 2 (EOP2) meeting in July with the U.S. Food and Drug Administration (FDA) to...

at 07:35
Zai Lab Announces Participation in May and June Investor Conferences
Zai Lab Limited today announced that members of the Company's senior management team will participate in the following investor conferences in May and June 2024: J.P. Morgan 20th Annual Global China Summit Panel Discussion: Thursday, May 23, 2024,...

at 07:35
Johnson & Johnson to Acquire Proteologix, Inc. to Lead in Atopic Dermatitis Treatment
Johnson & Johnson announced today that it has entered into a definitive agreement to acquire Proteologix, Inc., a privately-held biotechnology company focused on bispecific antibodies for immune-mediated diseases, for $850 million in cash, with...

at 07:35
Biogen and Ionis Announce Topline Phase 1/2 Study Results of Investigational Drug in Amyotrophic Lateral Sclerosis
Biogen Inc. and Ionis Pharmaceuticals, Inc. ...

More news about Health...


News published on and distributed by: